Stay updated with breaking news from Manisha Pai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON - Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration has approved CASGEVY , a CRISPR/Cas9 gene-edited cell therapy, for the treatment of...
- Longer-term follow-up data demonstrate consistent and durable response to treatment -BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced two oral presentations at the American Society of Hematology (ASH) Annual Meeting and Exposition from the global pivotal trials of CASGEVY...
BOSTON - Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics announced today that the U.S. Food and Drug Administration has approved CASGEVY , a CRISPR/Cas9 genome-edited cell therapy, for...
Vertex and CRISPR Therapeutics have announced FDA approval for CASGEVY in treating sickle cell disease. Utilizing cutting edge CRISPR/Cas9 gene editing technology, a patient’s own genes are extracted, edited, and then reinserted to eliminate sickle cell in this new therapy.